Post-procedural Pain Associated With 5 Versus 20 Intravesical Injections of Onabotulinumtoxin A
Status:
Recruiting
Trial end date:
2021-06-01
Target enrollment:
Participant gender:
Summary
Currently, in clinical practice there has been no standardization in the number of injections
a single dose of intradetrusor onabotulinumtoxin A is administered in. Given the increasing
use of this treatment modality, the aim of this study is to compare outcomes for patients
given a 100 unit dose of onabotulinumtoxin A split into 5 as compared to 20 injections for
the treatment of overactive bladder or urgency urinary incontinence refractory to medical
treatment.
Phase:
Phase 4
Details
Lead Sponsor:
University of South Florida
Collaborators:
Medstar Health Research Institute Washington Hospital Center